Výsledky vyhledávání - "Amputation/statistics & numerical data"

  1. 1

    Zdroj: European Journal of Endocrinology. 185:831-840

    Popis souboru: application/pdf

  2. 2

    Zdroj: Br J Surg
    Cervin, A, Ravn, H & Björck, M 2018, ' Ruptured popliteal artery aneurysm ', British Journal of Surgery, vol. 105, no. 13, pp. 1753-1758 . https://doi.org/10.1002/bjs.10953

    Popis souboru: application/pdf

  3. 3

    Zdroj: Diabetes, Obesity and Metabolism, Vol. 21, No 2 (2019) pp. 244-251

    Popis souboru: application/pdf

  4. 4

    Přispěvatelé: Sonia S Anand Jackie Bosch John W Eikelboom a další

    Zdroj: Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1
    Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S & COMPASS Investigators 2018, 'Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial', Lancet, vol. 391, no. 10117, pp. 219-229. https://doi.org/10.1016/S0140-6736(17)32409-1

    Témata: Carotid Artery Diseases, Male, Myocardial Infarction, MESH: Lower Extremity, THERAPY, Stroke/epidemiology, prevention, Hemorrhage/chemically induced, MESH: Peripheral Arterial Disease, MESH: Double-Blind Method, MESH: Incidence, guidelines, Cardiovascular Diseases/mortality, risk, MESH: Aged, RISK, MESH: Middle Aged, Incidence, Middle Aged, 3. Good health, MESH: Myocardial Infarction, Lower Extremity, MESH: Platelet Aggregation Inhibitors, Cardiovascular Diseases, Combination, Factor Xa Inhibitors/administration & dosage, Drug Therapy, Combination, Female, MESH: Factor Xa Inhibitors, Drug, OUTPATIENTS, MESH: Rivaroxaban, MESH: Hemorrhage, management, metaanalysis, Lower Extremity/blood supply, Rivaroxaban/administration & dosage, MESH: Dose-Response Relationship, Hemorrhage, MESH: Drug Administration Schedule, MESH: Stroke, Amputation, Surgical, Drug Administration Schedule, Dose-Response Relationship, MESH: Drug Therapy, Peripheral Arterial Disease, Drug Therapy, Double-Blind Method, atherothrombosis, MANAGEMENT, Myocardial Infarction/epidemiology, MESH: Amputation, Humans, MESH: Aspirin, Aspirin/administration & dosage, METAANALYSIS, Platelet Aggregation Inhibitors/administration & dosage, Aged, MESH: Humans, Aspirin, Dose-Response Relationship, Drug, MESH: Carotid Artery Diseases, MORTALITY, MESH: Cardiovascular Diseases, cardiovascular event rates, PREVENTION, MESH: Male, CARDIOVASCULAR EVENT RATES, outpatients, atrial-fibrillation, MESH: Morbidity, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Carotid Artery Diseases/complications, lower-extremity amputation, Peripheral Arterial Disease/complications, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Morbidity, MESH: Female, Amputation/statistics & numerical data, Factor Xa Inhibitors

    Popis souboru: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Zdroj: Lavery, L A, Armstrong, D G, Murdoch, D P, Peters, E J G & Lipsky, B A 2007, 'Validation of the Infectious Diseases Society of America's diabetic foot infection classification system', Clinical Infectious Diseases, vol. 44, no. 4, pp. 562-5. https://doi.org/10.1086/511036

  11. 11

    Zdroj: Peters, E J G, Lavery, L A & Armstrong, D G 2005, 'Diabetic lower extremity infection : influence of physical, psychological, and social factors', Journal of Diabetes and its Complications, vol. 19, no. 2, pp. 107-12. https://doi.org/10.1016/j.jdiacomp.2004.06.002

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Zdroj: International Working Group on the Diabetic Foot 2008, 'Reevaluating the way we classify the diabetic foot : restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot', Diabetes Care, vol. 31, no. 1, pp. 154-6. https://doi.org/10.2337/dc07-1302

  17. 17
  18. 18
  19. 19
  20. 20